Check out SCA Pharma’s Press Releases to stay updated on news about our company.
SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced today the addition of Hugh O’Neill as Chief Commercial Officer. O’Neill brings over 30 years of experience in the pharmaceutical industry. Most recently, Mr. O’Neill served as the Executive Vice President with…
Windsor, CT, November 1, 2022– SCA Pharma, a nationally recognized leader in the 503B compounded pharmaceuticals outsourcing industry, providing quality, service, and value to hospitals nationwide, has announced today that Vizient has awarded a multi-year agreement to the company for its full range of 503B ready-to-use products. Vizient is one of the nation’s leading health…
SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced today the addition of Louis Pace as Chief Financial Officer and Chief Information Officer. Pace brings over 30 years of experience serving several successful private equity backed businesses in functional and P&L…
On January 27, 2022, the FDA announced its decision to not include Glycopyrrolate on the 503B bulks list. Following this announcement, outsourcing facilities will not be permitted to compound the drug-using bulk API, unless the product appears in the future on the FDA’s drug shortage list. Glycopyrrolate is not currently on the drug shortage list.…
SCA Pharma, which provides high-quality sterile admixture services to hospitals and health-care facilities nationwide, has named Scott Luce as Chief Executive Officer.
SCA Pharma is proud to honor these essential front-line providers during National Nurses Month.
Reflecting its unequivocal commitment to leading the 503B compounded pharmaceuticals outsourcing industry in excellence, SCA Pharmaceuticals has named Abby Kaplan as General Counsel and Chief Compliance Officer.
In our ongoing effort to enhance our customers’ experience, SCA Pharma has responded to feedback and made several changes to the customer portal. Here are recent updates: On the home page, customers will find previously published communications, providing easy access to this information. A new interactive catalog is now available by clicking on the SCA…
SCA Pharmaceuticals continues its aggressive expansion and implementation of growth strategies, and in doing so, has appointed Joe Akers as Chief Operating Officer.
WINDSOR, CONN. (Jan. 28, 2021)– SCA Pharmaceuticals, LLC, announced details last week of their acquisition by The Vistria Group and Excellere. Continuing their strategic growth initiatives, SCA Pharma is announcing the appointment of Mr. Scott Luce as Chief Commercial Officer. Mr. Luce will provide leadership and oversight of commercial operations as SCA Pharma continues to…
WINDSOR, CONN. (Jan. 21, 2021) – SCA Pharmaceuticals, LLC (“SCA Pharma”), has entered into a definitive membership interest purchase agreement with The Vistria Group (“Vistria”) and Excellere Partners (“Excellere”). The Vistria Group and Excellere Partners have purchased all of the issued and outstanding equity interests of SCA Pharma. The terms of the transaction were not…
SCA Pharma just wrapped up the Health Connect Partners (HCP) Hospital Pharmacy fall virtual conference, where we shared a new virtual tour of the SCA Pharma facilities. The tour highlights the steps throughout the product journey, from receiving materials to compounding to packing and shipping the finished products to hospital pharmacies, and gives viewers an…
October is National Medicine Abuse Awareness Month, an annual effort by the Community Anti-Drug Coalitions of America to raise awareness of the dangers of prescription and over-the-counter medicine abuse. And SCA Pharma is partnering with hospital pharmacies to better control pain in patients safely. According to the Journal of the American Medical Association (JAMA), the…
SCA Pharma will exhibit at Health Connect Partners 2020 fall virtual conference.
SCA Pharma has signed an agreement with Kit Check™, a leader in automated and intelligent medication management solutions, allowing the company to add Kit Check’s embedded radio frequency identification (RFID) tag to all of its products, further ensuring the safety of its products for customers. SCA Pharma is the first 503B to use Kit Check’s…
SCA Pharma has recently extended its Kit Check program, providing customers confidence in the safety and quality of even more of its products. In addition , SCA Pharma now is a proud member of DoseID, the first member-driven industry consortium dedicated to the use of radio-frequency identification (RFID) technology in health care. DoseID’s goal is…
SCA Pharma, an FDA-registered outsourcing facility, today announced that it will expand its operations in Little Rock. SCA will be investing more than $10 million and will create the opportunity to double its current Little Rock workforce of 180 people. Additionally, the investment will allow SCA Pharma to renovate an existing 42,000-square-foot facility at the…
SCA Pharma, an FDA-registered outsourcing facility, plans to expand its sterile pharmaceutical manufacturing facility in Windsor, CT, by 40 percent. SCA Pharma has experienced continued growth during the past five years and has emerged as a leading manufacturer of compounded pharmaceuticals. The company continually seeks new opportunities to meet customer and patient needs, and creating…
SCA Pharma, partnering with Bausch Advanced Technologies, has compounded more than 2,500 containers of alcohol-based hand sanitizer now being distributed at no cost to first responders and front-line healthcare workers in Connecticut fighting the novel coronavirus (COVID-19). Hundreds of 100ml-sized containers already have been distributed to first response units located in Windsor, Simsbury, and Bloomfield.…
State, local and SCA Pharmaceuticals officials gathered recently to celebrate the opening of the company’s 90,000-square-foot manufacturing facility in Windsor. SCA Pharmaceuticals announced its plans to build the facility six months ago. Read the full story for the Hartford Courant here.
The private pharmaceutical company specializing in providing high quality sterile admixtures and prefilled syringes to hospitals and surgery centers, and located on Rainbow Road in Windsor, CT, celebrated the anniversary on November 27,2017. Governor Dannel P. Malloy and U.S. Senior Senator Richard Blumenthal highlighted a list of important guests on hand to help cut the ribbon. This new facility “helps…
Enhanced Healthcare Partners has made an investment in Little Rock, Arkansas-based SCA Pharmaceuticals, which specializing in preparing sterile pharmaceuticals for hospitals, pharmacies and healthcare facilities. No financial terms were disclosed. Read the full press release here.
SCA Pharma, a leading sterile outsourcing facility specializing in preparing customized pharmaceuticals for hospitals, pharmacies and healthcare facilities nationwide, is pleased to announce the appointment of Milton Boyer as Chief Executive Officer. Mr. Boyer, a veteran in the pharmaceutical industry, will succeed Dr. Gene Graves, SCA’s founder, who announced his retirement on September 6th. Mr. Boyer will also serve…